Lymphangioleiomyomatosis
📧 Sign up to get email alerts when something new happens for Lymphangioleiomyomatosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease [Phase 1]
Phase 1 trial evaluating bevacizumab and temsirolimus alone or with valproic acid or cetuximab in patients with advanced or metastatic malig…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis [Phase 1, Phase 2]
This clinical trial is evaluating nebulized or inhaled albuterol as a treatment for lymphangioleiomyomatosis in Phase 1 and Phase 2. The stu…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Study of the Disease Process of Lymphangioleiomyomatosis
NHLBI-sponsored clinical trial update focusing on the disease process of lymphangioleiomyomatosis, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Discovery of Sirolimus Sensitive Biomarkers in Blood [Phase 2]
Phase 2 clinical trial investigating sirolimus-sensitive biomarkers in the blood of patients with lymphangioleiomyomatosis; results have bee…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
A pregnancy registry for Tuberous Sclerosis Complex and Lymphangioleiomyomatosis is currently recruiting, sponsored by David M. Ritter.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Feasibility of [11C]Acetate-PET in LAM and TSC [Phase 1, Phase 2]
Phase 1/2 feasibility study evaluating [11C]Acetate-PET imaging in lymphangioleiomyomatosis and tuberous sclerosis complex. Results have bee…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM) [Phase 1]
A Phase 1 clinical trial update evaluating the long-term safety and tolerability of imatinib in patients with lymphangioleiomyomatosis (LAM)…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex
A University of Milan trial is recruiting to evaluate extracellular vesicles as biomarkers of pulmonary involvement in lymphangioleiomyomato…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: TSC Biosample Repository and Natural History Database
Recruiting study to create a biosample repository and natural history database for tuberous sclerosis complex and lymphangioleiomyomatosis.
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: National Lymphangioleiomyomatosis Registry, France
This entry reports on the National Lymphangioleiomyomatosis Registry in France, sponsored by Vincent Cottin. The study is currently recruiti…
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Safety and Durability of Sirolimus for Treatment of LAM
This clinical trial update reports ongoing safety and durability evaluation of sirolimus for lymphangioleiomyomatosis with recruitment conti…
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial [Phase 3]
A multicenter Phase 3 interventional trial for early-stage lymphangioleiomyomatosis is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases
This clinical trial update notes that the breath analysis and arterial stiffness study in patients with various respiratory diseases is curr…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: The Genotype and Phenotype of Lymphangioleiomyomatosis
This clinical trial update describes an ongoing genotype and phenotype study of lymphangioleiomyomatosis (including sporadic and TSC-associa…
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: Letrozole for Lymphangioleiomyomatosis [Phase 2]
Phase 2 clinical trial update for letrozole in lymphangioleiomyomatosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-02Clinical Trial Update: Efficacy and Safety of Sirolimus in LAM [Phase 3]
Phase 3 clinical trial assessing efficacy and safety of sirolimus in lymphangioleiomyomatosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial [Phase 2]
Phase 2 clinical trial evaluating resveratrol and sirolimus in lymphangioleiomyomatosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: A Study of Nintedanib for LymphAngioleioMyomatosis (LAM) [Phase 2]
Phase 2 clinical trial of nintedanib for lymphangioleiomyomatosis (LAM) has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Effect of Loratadine in Lymphangioleiomyomatosis [Phase 2]
Phase 2 trial assessing loratadine for lymphangioleiomyomatosis is listed with an unknown status.
-
CLINICAL_TRIALS trial_result · 2022-01-20Clinical Trial Update: COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC [Phase 2]
Phase 2 pilot trial of COX-2 inhibition in LAM completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis [Phase 2]
Phase 2 clinical trial updating safety and effectiveness of everolimus (RAD001) in lymphangioleiomyomatosis (LAM).
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: Safety of Simvastatin in LAM and TSC [Phase 1, Phase 2]
A Phase 1/2 trial reported on the safety of simvastatin in patients with Lymphangioleiomyomatosis and Tuberous Sclerosis Complex; study comp…
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: LAM Pilot Study With Imatinib Mesylate [Phase 1, Phase 2]
A pilot study investigating imatinib mesylate for lymphangioleiomyomatosis has completed Phase 1 and Phase 2 with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis [Phase 1]
Phase 1 safety study evaluating sirolimus with hydroxychloroquine in women with lymphangioleiomyomatosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients [NA]
A completed clinical trial evaluated whether a left-to-right shunt using veno-veno-arterial ECMO improves coronary oxygenation in lung trans…